为对比扎韦格潘（zavegepant）与口服 CGRP 受体拮抗剂治疗偏头痛的效果，研究发现前者起效快但长期优势不明显。 偏头痛，这种让人痛苦不堪的神经系统疾病，如同一个隐藏在暗处的 “小恶魔”，常常突然发起攻击。它以单侧或双侧搏动性头痛为典型特征 ...

Merck has announced that the antagonist of the calcitonin gene-related peptide (CGRP) receptor telcagepant has met the primary end points in two Phase III trials to treat migraine, which is ...